Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP138908121 | FDA panel backs Pfizer's COVID-19 vaccine for kids
CP135613271 | Merck: Experimental pill cuts worst COVID effects
CP137360871 | FDA panel backs lower-dose Moderna COVID booster
CP138845871 | FDA panel reviews Pfizer's COVID vaccine for kids
CP137329422 | FDA panel debates lower-dose Moderna COVID booster
FDA panel narrowly backs COVID-19 pill from Merck
A panel of U.S. health advisers narrowly backed a closely watched COVID-19 pill from Merck. The FDA panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy. (Dec. 1)
Actions
Add to collection
Add to cart
Information
Source name:
The Associated Press
Unique identifier:
CP143124202
Legacy Identifier:
480fd53c443c4f729c81e7eb49438d86
Type:
Video
Duration:
1m13s
Dimensions:
1920px × 1080px 89.87 MB
Usage rights:
Digital platform use only. Broadcast rights and editing of content prohibited.
Create Date:
11/30/2021 7:28:03 PM
Display aspect ratio:
16:9